DAVOTIFAN
UNII 59E92PRL8C

Substance Identification & Data

This profile provides standardized clinical and technical data for Davotifan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 59E92PRL8C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2925064-31-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

59E92PRL8C

CAS Registry Number

2925064-31-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAVOTIFAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H11F8NO3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KDOPXTXZTYNUGL-ZDUSSCGKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224727

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

168252441

Unique identification number in the NCBI database of chemical substances.

INN ID

13753

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S(C(F)(F)F)(=O)(=O)c1c2c(n(c1)-c3cc(C(F)F)c(F)cc3)CCC(F)(F)[C@H]2O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Davotifan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.